1226003

Doxycyclin -hyclat

United States Pharmacopeia (USP) Reference Standard

• Synonym(e): Doxycyclin-hydrochlorid Hemiethanolat Hemihydrat
• Empirische Formel (Hill-System): C₂₂H₂₄N₂O₈ · HCl · 0.5H₂O · 0.5C₂H₆O
• CAS-Nummer: 24390-14-5
• Molekulargewicht: 512.94
• Beilstein: 5702728
• MDL-Nummer: MFCD07357237
• UNSPSC-Code: 41116107
• PubChem Substanz-ID: 329749678
• NACRES: NA.24

Eigenschaften

• Qualität: pharmaceutical primary standard
• API-Familie: doxycycline
• Hersteller/Markenname: USP
• Anwendung(en): pharmaceutical (small molecule)
• Format: neat
• Lagertemp.: 2-8°C
• SMILES String: Cl[H].Cl[H].[H]O[H].CCO.C[C@@H]1C2[C@H](O)C3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C2C(=O)c4c(O)cccc14.C[C@@H]5C6[C@H](O)C7[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]7(O)C(O)=C6C(=O)c8c(O)cccc58
• InChI: 1S/2C22H24N2O8.C2H6O.2ClH.H2O/c2*1-7-8-5-4-6-9(25)11(8)16(26)12-10(7)17(27)14-15(24(2)3)18(28)13(21(23)31)20(30)22(14,32)19(12)29;1-2-3;;;/h2*4-7,10,14-15,17,25,27-29,32H,1-3H3,(H2,23,31);3H,2H2,1H3;2*1H;1H2/t2*7-,10?,14?,15-,17-,22-;;;;/m00..../s1
• InChIKey: HALQELOKLVRWRI-ZVACAFRPSA-N

Beschreibung

Allgemeine Beschreibung

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

Anwendung

Doxycycline hyclate USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia. Also, for use with USP monographs such as:

• Doxycycline Hyclate Tablets
• Doxycycline Hyclate Capsules
• Doxycycline Hyclate Delayed-Release Tablets
• Doxycycline Hyclate Delayed-Release Capsules
• Doxycycline Tablets
• Doxycycline Capsules

Biochem./physiol. Wirkung

Wirkungsweise: Doxycyclinhyclat hemmt die Entzündungsreaktion auf die Spirochäte Borrelia burgdorferi, den Erreger der Lyme-Krankheit.

Wirkungsspektrum: Wirksam gegen einen Breitspektrum-Inhibitor von Matrix-Metallproteinasen in vivo.

Hinweis zur Analyse

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.  ​

Sonstige Hinweise

Sales restrictions may apply.

Sicherheitshinweise

• Piktogramme: GHS08,GHS07
• Signalwort: Warning
• H-Sätze: H302,H315,H319,H335,H361fd,H412
• P-Sätze: P202 - P273 - P301 + P312 - P302 + P352 - P305 + P351 + P338 - P308 + P313
• Gefahreneinstufungen: Acute Tox. 4 Oral - Aquatic Chronic 3 - Eye Irrit. 2 - Repr. 2 - Skin Irrit. 2 - STOT SE 3
• Zielorgane: Respiratory system
• Lagerklassenschlüssel: 11 - Combustible Solids
• WGK: WGK 3
• Flammpunkt (°F): Not applicable
• Flammpunkt (°C): Not applicable